Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Dove Medical Press full text link Dove Medical Press Free PMC article
Full text links

Actions

Share

Review
.2019 Jul 17:12:2151-2160.
doi: 10.2147/IDR.S193649. eCollection 2019.

Staphyloxanthin: a potential target for antivirulence therapy

Affiliations
Review

Staphyloxanthin: a potential target for antivirulence therapy

Lijun Xue et al. Infect Drug Resist..

Abstract

Staphylococcus aureus is an important and common Gram-positive bacteria which causes clinical infections and food-poisoning cases. Therapeutic schedules for treatment ofS. aureus infections are facing a challenge because of the emergence of multidrug resistance strains. It is urgent to find new antiinfective drugs to control S. aureus infection. S. aureus strains are capable of producing the golden carotenoid pigment: staphyloxanthin, which acts as an important virulence factor and a potential target for antivirulence drug design. This review is aimed at presenting an updated overview of this golden carotenoid pigment of S. aureus from the biosynthesis of staphyloxanthin, its function, and the genes involved in pigment production to staphyloxanthin: a novel target for antivirulence therapy.

Keywords: antiinfective drug; antivirulence therapy; staphyloxanthin; target.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
The pathways of staphyloxanthin biosynthesis. The pigments were dissolved in ethyl acetate and the absorption spectra was measured.
Figure 2
Figure 2
The organization of thecrt genes in 58 published S. aureus genomes. The color of the arrows represents the color of the product encoded by corresponding gene.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Vandendriessche S, Vanderhaeghen W, Soares FV, et al. Prevalence, risk factors and genetic diversity of methicillin-resistant Staphylococcus aureus carried by humans and animals across livestock production sectors. J Antimicrob Chemother. 2013;68(7):1510–1516. doi:10.1093/jac/dkt047 - DOI - PubMed
    1. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999–2008. Arch Intern Med. 2012;172:363–365. doi:10.1001/archinternmed.2011.1027 - DOI - PMC - PubMed
    1. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–473. doi:10.1001/archinternmed.2008.603 - DOI - PMC - PubMed
    1. Fry DE. The continued challenge of Staphylococcus aureus in the surgical patient. Am Surg. 2013;79(1):1–10. - PubMed
    1. Allen RC, Popat R, Diggle SP, Brown SP. Targeting virulence: can we make evolution-proof drugs? Nat Rev Microbiol. 2014;12:300–308. doi:10.1038/nrmicro3232 - DOI - PubMed

Publication types

LinkOut - more resources

Full text links
Dove Medical Press full text link Dove Medical Press Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp